Chemical Inhibitors of Cyclin-Dependent Kinase (CDKi) Improve Pancreatic Endocrine Differentiation of iPS Cells

Researchers applied CDKi within a specific time window, which improved the efficiency of pancreatic endocrine cell induction. CDKi treatment reduced the prevalence of multi-layered regions and enhanced expression of PDX1 and NGN3.